Status:
COMPLETED
Comparison of 19g FNA and 19g FNB Needles for EUS-LB
Lead Sponsor:
Geisinger Clinic
Conditions:
Abnormal Liver Function
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an impor...
Eligibility Criteria
Inclusion
- Patients undergoing EUS-LB
- Platelet count \> 50,000
- International normalized ratio (INR) \< 1.5
- Age \> 18 years
- Non-pregnant patients
Exclusion
- Age \< 18 years
- Pregnant patients
- Inability to obtain consent
- Anticoagulants or anti-platelet agents use (excluding aspirin) within the last 7-10 days
- Platelet count \< 50,000
- INR \> 1.5
- Presence of ascites
- Known liver cirrhosis
- Hemophilia
Key Trial Info
Start Date :
October 2 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03408171
Start Date
October 2 2017
End Date
August 17 2018
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Medical Center
Danville, Pennsylvania, United States, 17822